Loading lessons…
Peptide learning paths
Learn peptides step by step
Curated lessons across 8 learning paths — from first concepts to trial summaries and practical protocols. Pick your level, follow the curriculum, and build real understanding.
Where are you starting?
284lessons
8paths
0day streak
0%explored
Start your first lesson
Choose a learning path below or search the library. Progress saves in your browser.
Prefer timeline chaos? Peptide X Quiz · Literacy certify
Learning paths
Pick a track — progress rings update as you complete lessons.
13 lessons
7mResearchAdvanced
MOTS-c's 503A Recommendation: What Changed and What Did Not
MOTS-c now has a favorable advisory recommendation. It still does not have FDA drug approval or an open 503A compounding path.
9mPeptidesIntermediate
MOTS-C and the Recovery Gap: Why Better Signaling Does Not Automatically Mean Better Recovery
MOTS-C keeps showing up in 2026 because it points at mitochondrial signaling. The trap is assuming that better signaling automatically means better recovery. It does not.
9mPeptidesIntermediate
MOTS-c and the Repair Paradox: Why a Metabolic Signal Is Not the Same as Healing
MOTS-c looks interesting because it can push metabolism in the right direction and still pull repair in the wrong one. The new data are a reminder that pathway activation and tissue healing are not the same thing.
9mPeptidesIntermediate
MOTS-C in July 2026: The FDA Review, Human Data, and What to Track
MOTS-C sits at the intersection of mitochondrial signaling, metabolism, and longevity. July 2026 put it back in the spotlight for a reason.
8mPeptidesIntermediate
MOTS-c and Cardiac Ischemia-Reperfusion: What the New Rat-Heart Study Shows
MOTS-c is showing up in cardiac stress research. A new rat-heart study points toward mitochondrial bioenergetics, mtDNA integrity, and post-ischemic recovery.
8mPeptidesIntermediate
MOTS-c and Inflammatory Lung Disease: What the New Research Suggests
MOTS-c is moving beyond generic energy claims. New research points toward mitochondrial stress response, lung inflammation, and cardiac reperfusion biology.
8mPeptidesIntermediate
MOTS-c and Arterial Stiffness: What the 2026 Pilot Study Shows
A new MOTS-c pilot study adds a vascular-health signal to the mitochondrial peptide conversation, but it should be read as biomarker research, not a protocol claim.
8mResearchAdvanced
MOTS-c and Mitochondrial Metabolism: What the 2026 Human Trial Is Testing
MOTS-c is one of the most interesting mitochondrial peptides in 2026 because the question is finally shifting from mechanism to human outcomes.
9mProtocolsIntermediate
The Complete GLP-1 + Mitochondrial Fat Loss Stack: Reta, MOTS-C, SS-31, AOD, and SLU-PP-332
Running Retatrutide and wondering what to add? This guide breaks down how MOTS-C, SS-31, AOD-9604, and SLU-PP-332 layer onto a GLP-1 protocol — and why they're not redundant.
7mPeptidesIntermediate
MOTS-C Dosing Guide: Recommended Dose and How to Take It
MOTS-C is one of the most studied mitochondrial peptides for metabolic health and longevity. This guide covers dosing ranges, frequency, timing, stacking options, and what to track on protocol.
9mPeptidesIntermediate
MOTS-c: The Mitochondrial Peptide Rewriting Longevity Science
Discovered inside mitochondrial DNA itself, MOTS-c is one of the most fascinating longevity peptides in modern science. It governs how your cells produce energy, fight fat accumulation, and age.
9mPeptidesIntermediate
MOTS-C: The Mitochondrial Peptide That Boosts Metabolism and Exercise Performance
MOTS-C is the first peptide found encoded in mitochondrial DNA. It activates AMPK, mimics exercise-induced metabolic adaptations, and may be one of the most powerful tools for metabolic optimization available.
10mPeptidesIntermediate
MOTS-C: The Peptide That Optimizes Mitochondrial Function
MOTS-C activates mitochondrial function and metabolic pathways linked to longevity and improved physical performance.
Also available at /blog for legacy links.